Skip to main content
Fig. 1 | BMC Cancer

Fig. 1

From: Notch signaling mutations increase intra-tumor chemokine expression and predict response to immunotherapy in colorectal cancer

Fig. 1

Notch signaling mutation activates immune responses in CRC. A The expressions of checkpoint and effector molecules in different groups of CRC patients in TCGA (P values were determined by the One-way ANOVA test. **p < 0.01, ***p < 0.001). B Proportions of patients with different CMS in mutation and WT groups. C Proportions of Notch mutation and WT patients in different CMS groups

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us